Apyx Medical Corporation
APYX
$0.958
$0.0788.86%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 23.81% | -5.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 23.81% | -5.45% | |||
| Cost of Revenue | 15.99% | -2.64% | |||
| Gross Profit | 28.90% | -7.19% | |||
| SG&A Expenses | 15.33% | -18.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.20% | -14.55% | |||
| Operating Income | 16.15% | 34.47% | |||
| Income Before Tax | 2.02% | 28.64% | |||
| Income Tax Expenses | 48.33% | 20.00% | |||
| Earnings from Continuing Operations | 1.38% | 28.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 47.62% | -30.00% | |||
| Net Income | 1.59% | 28.26% | |||
| EBIT | 16.15% | 34.47% | |||
| EBITDA | 16.76% | 35.24% | |||
| EPS Basic | 10.82% | 28.22% | |||
| Normalized Basic EPS | 11.50% | 28.63% | |||
| EPS Diluted | 10.82% | 28.22% | |||
| Normalized Diluted EPS | 11.50% | 28.63% | |||
| Average Basic Shares Outstanding | 10.31% | 0.00% | |||
| Average Diluted Shares Outstanding | 10.31% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
